Pesquisas alternativas:
complex atrial » complex bacterial (Expandir a Pesquisa), complex atypical (Expandir a Pesquisa)
nacl complex » nac56 complex (Expandir a Pesquisa), al complex (Expandir a Pesquisa), all complex (Expandir a Pesquisa)
atrial nihr » trial nihr (Expandir a Pesquisa), atrial air (Expandir a Pesquisa)
nay clamp » dnan clamp (Expandir a Pesquisa), a clamp (Expandir a Pesquisa), dna clamp (Expandir a Pesquisa)
gram oral » grams oral (Expandir a Pesquisa), grade oral (Expandir a Pesquisa), from oral (Expandir a Pesquisa)
oral 15 » oral 1.5 (Expandir a Pesquisa), oral 5 (Expandir a Pesquisa), oral 1 (Expandir a Pesquisa)
j nacl » 3 nacl (Expandir a Pesquisa), a nacl (Expandir a Pesquisa), 2 nacl (Expandir a Pesquisa)
j gram » j gray (Expandir a Pesquisa), j gran (Expandir a Pesquisa), j graf (Expandir a Pesquisa)
15 non » 05 non (Expandir a Pesquisa), 15 nov (Expandir a Pesquisa), 25 non (Expandir a Pesquisa)
j nay » j nagy (Expandir a Pesquisa), _ nay (Expandir a Pesquisa)
complex atrial » complex bacterial (Expandir a Pesquisa), complex atypical (Expandir a Pesquisa)
nacl complex » nac56 complex (Expandir a Pesquisa), al complex (Expandir a Pesquisa), all complex (Expandir a Pesquisa)
atrial nihr » trial nihr (Expandir a Pesquisa), atrial air (Expandir a Pesquisa)
nay clamp » dnan clamp (Expandir a Pesquisa), a clamp (Expandir a Pesquisa), dna clamp (Expandir a Pesquisa)
gram oral » grams oral (Expandir a Pesquisa), grade oral (Expandir a Pesquisa), from oral (Expandir a Pesquisa)
oral 15 » oral 1.5 (Expandir a Pesquisa), oral 5 (Expandir a Pesquisa), oral 1 (Expandir a Pesquisa)
j nacl » 3 nacl (Expandir a Pesquisa), a nacl (Expandir a Pesquisa), 2 nacl (Expandir a Pesquisa)
j gram » j gray (Expandir a Pesquisa), j gran (Expandir a Pesquisa), j graf (Expandir a Pesquisa)
15 non » 05 non (Expandir a Pesquisa), 15 nov (Expandir a Pesquisa), 25 non (Expandir a Pesquisa)
j nay » j nagy (Expandir a Pesquisa), _ nay (Expandir a Pesquisa)
1
Por Cramer, Daniel W., Fichorova, Raina N., Terry, Kathryn L., Yamamoto, Hidemi, Vitonis, Allison F., Ardanaz, Eva, Aune, Dagfinn, Boeing, Heiner, Brändstedt, Jenny, Boutron-Ruault, Marie-Christine, Chirlaque, Maria-Dolores, Dorronsoro, Miren, Dossus, Laure, Duell, Eric J, Gram, Inger T., Gunter, Marc, Hansen, Louise, Idahl, Annika, Johnson, Theron, Khaw, Kay-Tee, Krogh, Vittorio, Kvaskoff, Marina, Mattiello, Amalia, Matullo, Giuseppe, Merritt, Melissa A., Nodin, Björn, Orfanos, Philippos, Onland-Moret, N. Charlotte, Palli, Domenico, Peppa, Eleni, Quirós, J. Ramón, Sánchez, Maria-Jose, Severi, Gianluca, Tjønneland, Anne, Travis, Ruth C., Trichopoulou, Antonia, Tumino, Rosario, Weiderpass, Elisabete, Fortner, Renée T., Kaaks, Rudolf
Publicado no Cancer Epidemiol Biomarkers Prev (2018)
“...BACKGROUND: Neoplastic and non-neoplastic events may raise levels of mucins, CA15.3 and CA125...”Publicado no Cancer Epidemiol Biomarkers Prev (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Alosaimy, Sara, Pearson, Jeffrey, Veve, Michael, Dionne, Brandon, Aleissa, Muneerah, Jorgensen, Sarah C J, Rybak, Michael J
Publicado no Open Forum Infect Dis (2019)
“... for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by Gram-positive organisms...”Publicado no Open Forum Infect Dis (2019)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Shulder, Stephanie, O’Connell, Matthew, Agedal, Kaitlyn J, Conn, Kelly M, Pillinger, Kelly E
Publicado no Open Forum Infect Dis (2019)
“...BACKGROUND: While current guidelines suggest a total treatment duration of 7 to 14 days for gram...”Publicado no Open Forum Infect Dis (2019)
Obter o texto integral
Obter o texto integral
Artigo
4
“... options are doxycycline 100 mg x 2 for one week or azithromycin 1 gram single dose or 1,5 gram distributed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“...The extractable and bound lipids and cellular fatty acids of the gram-negative gliding bacteria...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Ledder, Ruth G., Kampoo, Kanokporn, Teanpaisan, Rawee, McBain, Andrew J.
Publicado no Front Microbiol (2018)
“...), the opposite trend was apparent for cavity-free children. Counts of Gram-negative anaerobes were significantly...”Publicado no Front Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“...The purpose of the study reported here was to investigate the impact of prophylaxis against gram...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Roura, Esther, Travier, Noémie, Waterboer, Tim, de Sanjosé, Silvia, Bosch, F. Xavier, Pawlita, Michael, Pala, Valeria, Weiderpass, Elisabete, Margall, Núria, Dillner, Joakim, Gram, Inger T., Tjønneland, Anne, Munk, Christian, Palli, Domenico, Khaw, Kay-Tee, Overvad, Kim, Clavel-Chapelon, Françoise, Mesrine, Sylvie, Fournier, Agnès, Fortner, Renée T., Ose, Jennifer, Steffen, Annika, Trichopoulou, Antonia, Lagiou, Pagona, Orfanos, Philippos, Masala, Giovanna, Tumino, Rosario, Sacerdote, Carlotta, Polidoro, Silvia, Mattiello, Amalia, Lund, Eiliv, Peeters, Petra H., Bueno-de-Mesquita, H. B(as)., Quirós, J. Ramón, Sánchez, María-José, Navarro, Carmen, Barricarte, Aurelio, Larrañaga, Nerea, Ekström, Johanna, Lindquist, David, Idahl, Annika, Travis, Ruth C., Merritt, Melissa A., Gunter, Marc J., Rinaldi, Sabina, Tommasino, Massimo, Franceschi, Silvia, Riboli, Elio, Castellsagué, Xavier
Publicado no PLoS One (2016)
“... was positively associated with CIN3/CIS risk (p-trend = 0.03). Duration of oral contraceptives use was associated...”Publicado no PLoS One (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Chetchotisakd, Ploenchan, Chierakul, Wirongrong, Chaowagul, Wipada, Anunnatsiri, Siriluck, Phimda, Kriangsak, Mootsikapun, Piroon, Chaisuksant, Seksan, Pilaikul, Jiraporn, Thinkhamrop, Bandit, Phiphitaporn, Sunchai, Susaengrat, Wattanachai, Toondee, Chalongchai, Wongrattanacheewin, Surasakdi, Wuthiekanun, Vanaporn, Chantratita, Narisara, Thaipadungpanit, Janjira, Day, Nicholas P, Limmathurotsakul, Direk, Peacock, Sharon J
Publicado em 2014
“...BACKGROUND: Melioidosis, an infectious disease caused by the Gram-negative bacillus Burkholderia...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“...-species, heterogeneous biofilm, consisting of both gram-positive and gram-negative species, and comprising...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Pullman, J, Gardovskis, J, Farley, B, Sun, E, Quintas, M, Lawrence, L, Ling, R, Cammarata, S
Publicado no J Antimicrob Chemother (2017)
“... or vancomycin 15 mg/kg plus aztreonam 2 g each administered twice daily intravenously for 5–14 days. Non...”Publicado no J Antimicrob Chemother (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Mersal, Ali, Alzahrani, Ibrahim, Azzouz, Mahasen, Alsubhi, Adel, Alsawaigh, Heba, Albshri, Nouf, Bajammal, Manal, Avand, Ghazal, Almahbosh, Abdulmajid
Publicado em 2013
“... Candida infection (ICI) in ELBW neonates; we conducted a randomized trial to compare oral nystatin...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Koh, Gavin C. K. W., Maude, Rapeephan R., Schreiber, M. Fernanda, Limmathurotsakul, Direk, Wiersinga, W. Joost, Wuthiekanun, Vanaporn, Lee, Sue J., Mahavanakul, Weera, Chaowagul, Wipada, Chierakul, Wirongrong, White, Nicholas J., van der Poll, Tom, Day, Nicholas P. J., Dougan, Gordon, Peacock, Sharon J.
Publicado em 2011
“... is an oral hypoglycemic agent used to treat diabetes mellitus. This K(ATP)-channel blocker and broad-spectrum...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“... transfusions were initiated. At 33 weeks she developed neutropenia (0.1 *10(9)/L) for which oral colistin...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Pelletier‐Galarneau, Matthieu, Hunter, Chad R. R. N., Ascah, Kathryn J., Beanlands, Rob S. B., Dwivedi, Girish, deKemp, Robert A., Chow, Benjamin J. W., Ruddy, Terrence D.
Publicado no J Am Heart Assoc (2017)
“... and not different at baseline (0.65±0.19 versus 0.60±0.15 mL/min per gram, P=0.084) and at high‐dose adenosine (1.64...”Publicado no J Am Heart Assoc (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Canale, Robert E., Farney, Tyler M., McCarthy, Cameron G., Bloomer, Richard J.
Publicado em 2011
“... in response to a modified oral glucose tolerance test (OGTT). METHODS: Using a randomized, double-blind, cross...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Overcash, J Scott, O’Riordan, William, Quintas, Megan, Lawrence, Laura, Tseng, Carol, Cammarata, Sue
Publicado no Open Forum Infect Dis (2019)
“...BACKGROUND: Delafloxacin (DLX), an IV/oral anionic fluoroquinolone antibiotic, is approved...”Publicado no Open Forum Infect Dis (2019)
Obter o texto integral
Obter o texto integral
Artigo
18
Por Keepers, Tiffany R, Cebrik, Deborah S, Cloutier, Daniel J, Komirenko, Allison, Connolly, Lynn, Krause, Kevin
Publicado no Open Forum Infect Dis (2018)
“... with cUTI or AP. Patients received IV PLZ (15 mg/kg q24h) or IV MEM (1 g q8h) for 4–7 days, followed...”Publicado no Open Forum Infect Dis (2018)
Obter o texto integral
Obter o texto integral
Artigo
19
Por Hasnaa Makkawi, Shifra Hoch, Elia Burns, Kavita Hosur, George Hajishengallis, Carsten J. Kirschning, Gabriel Nussbaum
Publicado em 2017-08-01
“...Porphyromonas gingivalis is a gram-negative anaerobic periodontal pathogen that persists...”Publicado em 2017-08-01
Obter o texto integral
Artigo
20
Por Karaiskos, Ilias, Galani, Lambrini, Sakka, Vissaria, Gkoufa, Aikaterini, Sopilidis, Odysseas, Chalikopoulos, Dimitrios, Alivizatos, Gerasimos, Giamarellou, Eleni
Publicado no J Antimicrob Chemother (2019)
“... to fosfomycin (median MIC for Gram-negative pathogens 1.5 mg/L). In 25 patients, treatment was administered...”Publicado no J Antimicrob Chemother (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo